SPP1 and neoplasm: As a key regulator of metastasis, inflammation, and ECM remodeling, OPN represents a promising therapeutic target for inhibiting tumor growth and metastasis, overcoming immune suppression, and enhancing the efficacy of existing cancer therapies.